Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, producing wide-ranging effects on appetite, digestion, and metabolism
CVS Caremark, which controls pharmacy benefits for tens of millions of Americans, kept Wegovy as its preferred GLP-1 in mid-2025 creating a smoother path than many patients expect
If coverage is denied for weight loss but you also have type 2 diabetes, talk to your clinician about whether the diabetes indication and the appropriate product apply to your situation
By following the prescribed treatment plan and making healthy lifestyle choices, you can achieve lasting weight loss and enjoy the benefits of improved health
Please refrigerate, to keep solid form, and maintain potency